Trade Mark Journal No.2026/029 17 July 2026
UK00004414269 10 July 2026 (5)

International priority date claimed: 17 February 2026
(United States of America)
(99656120)
- Class 5
- Pharmaceutical preparations; pharmaceutical preparations used for the treatment of cancer; Pharmaceutical preparations for use in oncology.
Inhibrx Biosciences, Inc.
Representative: Birketts LLP